Beximco Pharmaceuticals Limited (LON:BXP – Get Free Report) shares reached a new 52-week high during trading on Monday . The stock traded as high as GBX 65 and last traded at GBX 64.80, with a volume of 39710 shares. The stock had previously closed at GBX 59.55.
Beximco Pharmaceuticals Stock Up 8.8%
The stock has a fifty day moving average price of GBX 55.75 and a 200 day moving average price of GBX 47.62. The company has a debt-to-equity ratio of 5.27, a current ratio of 4.13 and a quick ratio of 0.37. The stock has a market capitalization of £289.08 million, a P/E ratio of 0.03 and a beta of 0.25.
About Beximco Pharmaceuticals
Beximco Pharma is a leading manufacturer and exporter of medicines based in Bangladesh. Incorporated in 1976, the Company started its operation by importing products from Bayer, Germany and Upjohn, USA and selling them in the local market. In 1980, Beximco Pharma began manufacturing of these products under licensing arrangement and in 1983 launched its own formulation brands. Since its inception, the Company remains committed to health and wellbeing of people across all the continents by providing access to contemporary medicines.
Read More
- Five stocks we like better than Beximco Pharmaceuticals
- Coach’s Momentum Powers Tapestry Despite the Stock’s Sharp Pullback
- AI Is Reshaping SaaS—These 2 Software ETFs Offer Different Ways to Play It
- Insiders Signal Deep Value In DICK’s Sporting Goods
- 3 Retail Dips Backed by Rising Consumer Demand
Receive News & Ratings for Beximco Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beximco Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
